Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
At Clinipace, we provide an unparalleled level of collaboration and control that far exceeds what is typically available in conventional CRO settings. Our mission is to effectively guide you through the complexities of your clinical development program. As a global, full-service contract research organization, we prioritize a personalized approach to clinical research. We emphasize flexibility and collaboration, complemented by our regulatory expertise and leadership in various therapeutic areas. Our goal is to transform the landscape of clinical research across numerous fields, including oncology, rare diseases, gastroenterology, nephrology, and women's health. By integrating cutting-edge technology and an adaptive mindset, Clinipace is dedicated to shaping the future of drug development and enhancing healthcare outcomes. Our commitment to innovative solutions ensures that we remain at the forefront of industry advancements.
Description
Introducing a versatile API designed to seamlessly integrate with your diabetes management system, offering tailored therapeutic education and enhanced insights into blood glucose level fluctuations. This solution enables real-time risk predictions, fostering greater personalization and improved system regulation, while adeptly managing complex living scenarios characterized by rapid glucose variations. With advancements in telemedicine and retrospective analysis, patients receive robust decision-support tools. Currently, Hillo is developing the next iterations of its AI technology, which includes a therapeutic recommendation system aimed at preventing hypoglycemia and hyperglycemia, anticipated to achieve CE mark class IIB by 2020. Additionally, a new generation of the artificial pancreas is projected for release in 2021, addressing key limitations of existing systems through ultra-personalization driven by machine learning. This innovative approach marks the introduction of the first self-learning artificial intelligence capable of predicting blood glucose levels, aiming to secure a CE mark as a medical device, thereby transforming diabetes management for users. In essence, Hillo's advancements could significantly enhance the quality of life for individuals managing diabetes.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Clinipace
Founded
2003
Country
United States
Website
www.clinipace.com
Vendor Details
Company Name
Hillo
Country
France
Website
www.hillo.ai/
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
Document Management
Electronic Data Capture
Enrollment Management
HIPAA Compliant
Monitoring
Patient Database
Recruiting Management
Scheduling
Study Planning